IQV

IQVIA Holdings Inc.

Price

$208.99

return (12m)

4.07%

p/e

25.09

p/bv

5.47

DIVIDEND YIELD

0.00%

IQV price

IQVIA Holdings

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment IQV

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

12.59%

3 months

28.78%

1 year

4.07%

2 years

-12.47%

5 years

-16.10%

10 years

178.65%

Fundamentals IQV

Valuation

P/E

25.09

Sector -2.25

Industry -6.50

P/BV

5.47

Sector 2.19

Industry 1.84

P/Revenue (PSR)

2.09

Sector 2.02

Industry 3.16

EV/EBITDA

57.73

Sector -25.25

Industry -32.04

EV/EBIT

89.70

Sector -37.87

Industry -46.97

P/EBITDA

9.88

Sector -0.06

Industry -2.98

P/EBIT

14.78

Sector -2.02

Industry -5.91

P/Total Assets

1.17

Sector 1.18

Industry 1.24

P/Ativo Circ. Liq.

-2.03

Sector -10.50

Industry -7.51

P/Cap.Giro

-16.48

Sector 0.13

Industry 1.02

EPS

8.24

Sector -0.92

Industry -1.36

BVPS

37.79

Sector 3.93

Industry 2.10

Efficiency

Gross Margin

32.99%

Sector 44.22%

Industry 46.63%

EBITDA Margin

19.47%

Sector -312.86%

Industry -17,123,075.56%

EBIT Margin

12.53%

Sector -193.59%

Industry -17,075,545.37%

Operating Margin

13.99%

Sector -25.72%

Industry -34.57%

Net Profit Margins

8.33%

Sector -30.17%

Industry -37.93%

Giro Ativos

0.14

Sector 0.12

Industry 0.05

Profitability

ROE

21.81%

Sector -34.36%

Industry -48.45%

ROA

4.67%

Sector -28.49%

Industry -52.44%

ROIC

6.50%

Sector -439.00%

Industry -520.61%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

0.75

Sector 1.88

Industry 2.33

Dívida Líquida/EBITDA

14.71

Sector -1.67

Industry -2.05

Dívida Líquida/EBIT

22.86

Sector -0.92

Industry -2.06

Dívida Líquida/Patrimônio

1.87

Sector -0.35

Industry -0.87

Dívida Bruta/Patrimônio

2.20

Sector 0.15

Industry -0.18

Equity/Assets

0.21

Sector 0.43

Industry 0.47

Liabilities/Assets

0.79

Sector 0.46

Industry 0.41

Growth

5Y Revenue CAGR

3.69%

Sector -

Industry -

5Y Earnings CAGR

7.47%

Sector -

Industry -

FAIR VALUE OF IQVIA Holdings ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$208.99

Fair Value

$83.70

Upside Return potential.

-59.95%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals IQV

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
IQV	25.09	5.47	21.81%	0.00%	$34.76 B	8.33%
LLY	41.74	33.82	81.02%	0.55%	$1.06 T	34.99%
ISRG	39.67	6.81	17.15%	0.00%	$124.53 B	28.45%
SNY	7.21	1.28	17.79%	4.00%	$107.73 B	14.75%
NVS	21.74	7.56	34.77%	2.01%	$294.21 B	23.92%
TMO	29.07	3.82	13.15%	0.34%	$199.09 B	15.15%
ABT	25.64	3.09	12.06%	0.00%	$160.92 B	13.91%
MDT	22.18	2.13	9.59%	3.43%	$106.50 B	13.20%
GSK	13.20	4.46	33.77%	3.41%	$103.53 B	17.79%
CVS	46.88	1.77	3.78%	2.46%	$137.46 B	0.72%
BSX	18.45	2.54	13.78%	0.00%	$65.78 B	17.29%
TMDX	14.70	5.12	34.80%	0.00%	$2.53 B	27.04%
IDXX	41.21	29.00	70.38%	0.00%	$45.13 B	24.63%
RMD	19.01	4.45	23.41%	1.20%	$28.89 B	27.44%
HCA	12.41	-28.31	-228.14%	0.80%	$84.32 B	8.89%
DHR	38.96	2.71	6.97%	0.67%	$143.74 B	14.89%
SYK	36.85	5.35	14.52%	1.07%	$122.99 B	13.21%
PHG	22.75	1.95	8.56%	3.75%	$25.71 B	5.50%
COHR	114.66	4.88	4.26%	0.00%	$53.76 B	7.10%
INMD	11.26	1.48	13.18%	0.00%	$981.23 M	23.27%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

IQV Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT IQVIA Holdings

IQVIA Holdings Inc.

Average Investor10 user rating

4.0 (4 people)

United States

44 years

Founded: 1982

2013

Time since IPO - 13 years

79.000

Employees

IQVIA Holdings Inc. (United States) is listed on the NYSE and has a market capitalization of $34.76 billion, with shareholders equity totaling $6.35 billion.

The company employs approximately 79.000 people and operates in the Health sector, within the Life Science Tools and Services industry.

Over the past 12 months, IQVIA Holdings Inc. reported $16.63 billion in revenue, generating net income of $1.39 billion.

Key financial metrics include a P/E ratio of 25.09, a price-to-book (P/B) ratio of 5.47, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker IQV.

Market cap

$34.76 billion

Net worth

$6.35 billion

$6,349,000,000.00

Assets

$29.68 billion

$29,675,000,000.00

Total Shares Outstanding

168.00 million

168,000,000

Average Daily Trading Volume

$1.57 million

$1,569,378.00

Sector

Health

Industry

Life Science Tools and Services

IQV

revenue by Business Segment IQVIA Holdings

Revenue by Region IQVIA Holdings

IQV revenue and profits

Financial Results IQV

DRAG THE FRAME TO SEE MORE DATA

IQV cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$107.64 84,93% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$288.18 --0,62% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$63.51 123,71% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$394.56 68,19% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$43.41 --10,42% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$1,201.79 49,99% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$385.14 15,96% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$155.45 34,63% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56